A Phase II Study of Milataxel (TL139) Administered Orally or Intravenously in Taxane Naive Patients with Metastatic Breast Cancer.

Trial Profile

A Phase II Study of Milataxel (TL139) Administered Orally or Intravenously in Taxane Naive Patients with Metastatic Breast Cancer.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 13 Jul 2016

At a glance

  • Drugs Milataxel (Primary) ; Milataxel (Primary)
  • Indications Advanced breast cancer
  • Focus Adverse reactions
  • Sponsors Taxolog
  • Most Recent Events

    • 21 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top